Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Coupier

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2005
Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriersDavid J Hughes, Sophie M Ginolhac, Isabelle Coupier, et al.
Journal of Medical Genetics|June 9, 2017
Germline <i>CDKN2A</i>/P16INK4A mutations contribute to genetic determinism of sarcomaFanélie Jouenne, Isaure Chauvot de Beauchene, Emeline Bollaert, et al.
European Journal of Human Genetics : EJHG|August 10, 2018
Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendationsPascal Pujol, Pierre Vande Perre, Laurence Faivre, et al.
Breast Cancer Research : BCR|April 19, 2018
Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriersAnne-Laure Renault, Noura Mebirouk, Laetitia Fuhrmann, et al.
Cancers|April 14, 2025
Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair GenesMaximiliano Ribeiro-Guerra, Marie-Gabrielle Dondon, Séverine Eon-Marchais, et al.
International Journal of Cancer|December 28, 2020
Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibilityChristine Lonjou, Séverine Eon-Marchais, Thérèse Truong, et al.
Breast Cancer Research : BCR|August 4, 2021
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutationMaximiliano Ribeiro Guerra, Juliette Coignard, Séverine Eon-Marchais, et al.
Journal of Medical Genetics|March 15, 2011
Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinomaBetty Gardie, Audrey Remenieras, Darouna Kattygnarath, et al.
European Journal of Human Genetics : EJHG|April 16, 2015
Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer riskStéphanie Baert-Desurmont, Françoise Charbonnier, Estelle Houivet, et al.
American Journal of Obstetrics and Gynecology|January 25, 2021
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort studyLieske H Schrijver, Antonis C Antoniou, Håkan Olsson, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2005
Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriersDavid J Hughes, Sophie M Ginolhac, Isabelle Coupier, et al.
Journal of Medical Genetics|June 9, 2017
Germline <i>CDKN2A</i>/P16INK4A mutations contribute to genetic determinism of sarcomaFanélie Jouenne, Isaure Chauvot de Beauchene, Emeline Bollaert, et al.
European Journal of Human Genetics : EJHG|August 10, 2018
Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendationsPascal Pujol, Pierre Vande Perre, Laurence Faivre, et al.
Breast Cancer Research : BCR|April 19, 2018
Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriersAnne-Laure Renault, Noura Mebirouk, Laetitia Fuhrmann, et al.
Cancers|April 14, 2025
Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair GenesMaximiliano Ribeiro-Guerra, Marie-Gabrielle Dondon, Séverine Eon-Marchais, et al.
International Journal of Cancer|December 28, 2020
Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibilityChristine Lonjou, Séverine Eon-Marchais, Thérèse Truong, et al.
Breast Cancer Research : BCR|August 4, 2021
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutationMaximiliano Ribeiro Guerra, Juliette Coignard, Séverine Eon-Marchais, et al.
Journal of Medical Genetics|March 15, 2011
Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinomaBetty Gardie, Audrey Remenieras, Darouna Kattygnarath, et al.
European Journal of Human Genetics : EJHG|April 16, 2015
Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer riskStéphanie Baert-Desurmont, Françoise Charbonnier, Estelle Houivet, et al.
American Journal of Obstetrics and Gynecology|January 25, 2021
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort studyLieske H Schrijver, Antonis C Antoniou, Håkan Olsson, et al.
Pageof 7